Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Core Insights - Beyond Air, Inc. has expanded its international distribution network for the LungFit PH system, now covering 18 countries following new agreements in France, Turkey, Romania, and Morocco [1][2] - The company anticipates a rapid commercial ramp-up in international markets, leveraging established distribution partners with medical device infrastructure [2] Distribution Agreements - Recent agreements include partnerships with EUROCARE for France, Medelart Healthcare for Turkey, Abb Neopuls for Romania, and OXYPLUS for Morocco [1][2] - The current distribution partners also include Getz Healthcare across multiple Asian countries, Saudi Health Services CO in Saudi Arabia, and MDC Care Medical Trading in the UAE and surrounding regions [2] Product Overview - LungFit PH is a tankless system that generates nitric oxide (NO) from room air, enhancing operational efficiency and supporting sustainability in hospital settings [3][4] - The device can deliver NO at concentrations ranging from 1 ppm to 80 ppm, with potential applications in treating severe acute lung infections and chronic lung infections [4][5] Regulatory Status - LungFit PH is approved for commercial use in the United States, European Union, Australia, Thailand, and New Zealand [6] - The system is designated as a medical device by the U.S. FDA and is intended for use in treating hypoxic respiratory failure in neonates [9] Therapeutic Applications - Nitric oxide plays a critical role in various biological functions and is used in treating conditions such as adult respiratory distress syndrome and persistent pulmonary hypertension [7] - Exogenous inhaled NO is believed to have antimicrobial properties, potentially effective against a range of pathogens, including multi-drug-resistant strains [8]